What are macrophages? Study reveals crucial genetic mutation behind Crohn's disease

Macrophages can alternate between two states: an inflammatory state for fighting infection and a non-inflammatory state for ...

Agomab Announces Positive Topline Phase 2a Data for Ontunisertib in Fibrostenosing Crohn’s Disease

STENOVA trial achieves primary endpoint in 103 study participants after 12 weeks of treatment -- -- Pharmacokinetic results confirm ...

Vitamin B12 Deficiency Can Affect Your Memory And Overall Cognitive Function; Tips To Boost Levels

Fatigue, pale skin, headaches, gastrointestinal issues, increased inflammation, pain, muscle cramps and vision disturbances ...

Jaguar Health Provides Recap of November 8, 2025 Presentation on Groundbreaking Results of Proof-of-Concept Study of Crofelemer for Treatment of Pediatric Intestinal Failure at ...

Crofelemer can potentially extend and save lives of microvillus inclusion disease patients, reducing the volume of the total parenteral support (PS) necessary for them to survive Groundbreaking PS ...
Mirage News

UOC Researchers Win Canterbury Medical Research Grants

University of Otago, Christchurch Ōtautahi researchers investigating cures for cancer, heart disease, inflammatory bowel ...

New long-term data reinforces TREMFYA® (guselkumab) as the only IL-23 inhibitor proven to substantially inhibit structural joint damage in active psoriatic arthritis

Johnson & Johnson (NYSE: JNJ) today announced new data from the Phase 3b APEX study showing that TREMFYA® continued to reduce both signs and symptoms of active psoriatic arthritis (PsA) and inhibit ...